Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study

BK virus-associated nephropathy (PvAN) increases the risk of graft failure justifying treatment. Conversion to mammalian target of rapamycin inhibitors (mTORi) and Human polyclonal immunoglobulins (IVIg) could prevent the risk of PvAN. Our retrospective study assessed the efficacy of mTORi associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Vela, Carla, Jouve, Thomas, Chevallier, Eloi, Imerzoukene, Farida, Germi, Raphaële, Le Marechal, Marion, Truffot, Aurélie, Fiard, Gaëlle, Janbon, Bénédicte, Giovannini, Diane, Malvezzi, Paolo, Rostaing, Lionel, Noble, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785214/
https://www.ncbi.nlm.nih.gov/pubmed/36555909
http://dx.doi.org/10.3390/jcm11247292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785214/
https://www.ncbi.nlm.nih.gov/pubmed/36555909
http://dx.doi.org/10.3390/jcm11247292

Ejemplares similares